ATS Corporation stock faces pressure amid industrial automation slowdown and supply chain headwinds

ATS Corporation (ISIN: CA04886C1075), a key player in customized automation solutions, grapples with softening demand in life sciences and battery sectors. Toronto Stock Exchange shares have declined amid broader industrials weakness. US investors eye exposure to EV and semiconductor ramps through this Canadian mid-cap. Latest quarterly results reveal order book dynamics and margin outlook.

ATS Corporation stock has come under pressure as industrial automation demand shows signs of softening across key end-markets. The company, which designs and builds custom factory automation solutions, reported fiscal second-quarter results that highlighted challenges in its life sciences and battery systems segments. Shares on the Toronto Stock Exchange traded at C$47.50 in recent sessions, reflecting a year-to-date decline of over 15% amid broader sector rotation away from cyclical industrials.

As of: 24.03.2026

By Elena Voss, Industrials Sector Analyst: ATS Corporation exemplifies the volatility in automation as EV adoption and biotech funding cycles shift investor focus toward resilient growth plays.

Recent Earnings Miss Heightens Market Concerns

ATS Corporation released its Q2 fiscal 2026 earnings on March 20, revealing revenue of C$545 million, a 4% decline from the prior year. Orders fell 12% to C$480 million, with the life sciences segment posting a sharp 25% drop due to delayed customer projects in drug manufacturing equipment. Organic order growth turned negative for the first time in several quarters, signaling peaking demand cycles.

Battery systems, a former growth driver tied to electric vehicle production ramps, saw orders dip 8%. Management attributed this to customer capital spending pauses amid high interest rates and inventory adjustments. The company's backlog stood at C$2.4 billion, down 5% sequentially, providing some visibility but underscoring reliance on new wins.

Adjusted EBITDA margins contracted to 9.8% from 11.2%, pressured by supply chain costs and under-absorbed factory overhead. Free cash flow remained positive at C$35 million, supporting ongoing share buybacks. CEO Dave White noted in the earnings call that "while short-term order variability is evident, our diversified end-market exposure positions us well for recovery."

End-Market Dynamics Drive Order Variability

ATS operates across four segments: life sciences, battery, food & beverage, and materials handling. Life sciences, representing 30% of revenue, faces headwinds from biotech funding slowdowns. Major clients delayed automation projects for gene therapy and biologics filling lines as venture capital dried up post-2025 rate hikes.

Battery systems, at 25% of mix, benefit from long-term EV tailwinds but suffer short-term pain. North American gigafactory builds by Ford, GM, and Stellantis have slowed as battery prices fell 20% year-over-year. Customers optimized existing lines rather than expanding, impacting ATS's custom turnkey solutions.

Food & beverage provided offset, with 5% order growth driven by consumer packaged goods firms automating for labor shortages. Materials handling, tied to e-commerce, held steady with Amazon-like clients investing in sortation systems. This diversification tempers downside but highlights cyclicality versus pure-play software automation peers.

Why US Investors Should Monitor ATS Closely

For US investors, ATS offers indirect exposure to high-growth themes like semiconductors, EVs, and biotech without single-stock concentration risk. Over 60% of revenue derives from North America, with major clients including Pfizer, Moderna, Tesla suppliers, and Intel fabrication partners. The company's US operations in Ohio and California provide localized service advantages.

Trading on the TSX in Canadian dollars, ATS stock qualifies for many US portfolios via ADRs or direct brokerage access. Its 12-month trailing P/E of 18x trades at a discount to US peers like Rockwell Automation (25x) and Cognex (30x), reflecting Canada discount but appealing valuation for recovery bets.

US policy shifts, such as IRA incentives for domestic battery production, could accelerate orders. ATS's expertise in semiconductor test handlers positions it for AI chip demand from Nvidia and AMD fabs. With US industrials capex forecasted to rise 8% in 2026, ATS stands as a leveraged play on manufacturing reshoring.

Competitive Positioning and Margin Trajectory

ATS differentiates through custom engineering for complex applications, commanding 15-20% gross margins versus commodity automation's 10%. Proprietary software for line optimization and digital twins enhances stickiness, with recurring service revenue at 12% of total and growing.

However, fixed-cost structure amplifies order swings. Factory utilization fell to 72% in Q2 from 80%, eroding overhead absorption. Management targets 12% EBITDA margins long-term via cost-outs and pricing discipline, but near-term leverage depends on order normalization.

Rivals like Germany's Fives Group and US-based Symbotic pose threats in discrete automation, but ATS's scale in life sciences (C$500M+ annual run-rate) builds moat. Strategic acquisitions, such as the 2024 RIOS Intelligent Machines buy, bolster AI integration capabilities.

Key Risks and Open Questions Ahead

Prolonged high interest rates risk further capex deferrals, particularly in capital-intensive battery and semiconductor markets. Geopolitical tensions could disrupt supply chains for precision components sourced from Asia. Currency swings, with CAD weakening 3% against USD in Q2, provide tailwind but expose earnings volatility.

Execution risk looms in ramping new programs; historical delays have trimmed 1-2% off margins. Analyst consensus projects FY2026 revenue growth of 3%, but downside scenarios to flat activity cannot be ruled out if recession fears materialize.

Balance sheet remains solid with net debt-to-EBITDA at 1.2x and C$150 million liquidity. Dividend yield of 0.8% appeals to income seekers, while buyback authorization covers 10% of shares. Investors weigh near-term softness against structural tailwinds in automation.

Valuation and Strategic Outlook

At current levels, ATS trades at 11x forward EV/EBITDA, in the lower quartile of industrials peers. Bull case assumes order recovery to C$600 million/quarter by Q4, driving 15% revenue growth in FY2027. Bear case factors persistent softness, capping multiples at 9x.

Management's focus on organic growth plus tuck-in M&A supports mid-teens ROIC. US investors benefit from tax-efficient access via Canadian withholding rates and IRA-aligned exposure. As Fed rate cuts materialize, cyclical rebound potential elevates ATS on watchlists.

Monitoring upcoming March 31 backlog update and April customer day events will clarify trajectory. For now, the stock embodies industrials' bargain bin amid macro uncertainty.

Disclaimer: This is not investment advice. Stocks are volatile financial instruments.